We are live on ! Find out more
HUMA icon

Humacyte
HUMA

123 hedge funds and large institutions have $150M invested in Humacyte in 2024 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 14

171% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 17

107% more capital invested

Capital invested by funds: $72.4M → $150M (+$77.4M)

28% more funds holding

Funds holding: 96 → 123 (+27)

6.3% more ownership

Funds ownership: 19.91% → 26.2% (+6.3%)

8% less call options, than puts

Call options by funds: $3.34M | Put options by funds: $3.61M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
123
Holders Change
+27
Holders Change %
+28.13%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
46
Increased
51
Reduced
14
Closed
17
Calls
$3.34M
Puts
$3.61M
Net Calls
-$272K
Net Calls Change
+$483K

Top Buyers

1
BlackRock
BlackRock
New York
+$12.2M
2
State Street
State Street
Massachusetts
+$8.62M
3
Millennium Management
Millennium Management
New York
+$6.95M
4
N
Nuveen
North Carolina
+$6.05M
5
Two Sigma Investments
Two Sigma Investments
New York
+$5.81M

Top Sellers

1
ACM
AIGH Capital Management
Maryland
-$6.71M
2
SCM
Sio Capital Management
New York
-$6.22M
3
MIM
Monashee Investment Management
Massachusetts
-$3.75M
4
PGP
Prescott General Partners
Florida
-$1.77M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$34.3M +$12.2M +2,351,274 +49%
Vanguard Group
2
Vanguard Group
Pennsylvania
$22.7M +$3.69M +709,913 +18%
State Street
3
State Street
Massachusetts
$13.8M +$8.62M +1,655,896 +137%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$8.93M +$2.66M +510,560 +38%
Millennium Management
5
Millennium Management
New York
$7.68M +$6.95M +1,334,641 +504%
N
6
Nuveen
North Carolina
$5.97M +$6.05M +1,161,900 +1,421%
Two Sigma Investments
7
Two Sigma Investments
New York
$5.48M +$5.81M +1,116,414 +4,356%
Goldman Sachs
8
Goldman Sachs
New York
$3.66M +$3.45M +662,723 +670%
Voloridge Investment Management
9
Voloridge Investment Management
Florida
$3.3M +$3.58M +687,296 New
Charles Schwab
10
Charles Schwab
California
$3.14M +$940K +180,605 +38%
Renaissance Technologies
11
Renaissance Technologies
New York
$2.88M +$2.73M +524,600 +693%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$2.81M +$2.71M +520,124 +790%
Northern Trust
13
Northern Trust
Illinois
$2.75M +$118K +22,717 +4%
Marshall Wace
14
Marshall Wace
United Kingdom
$2.23M +$2.34M +450,031 +3,302%
LPL Financial
15
LPL Financial
California
$2.22M +$225K +43,157 +10%
PAG
16
Private Advisor Group
New Jersey
$1.76M +$255K +48,976 +15%
DM
17
Deerfield Management
New York
$1.55M +$1.68M +322,851 New
MIM
18
Monashee Investment Management
Massachusetts
$1.34M -$3.75M -720,000 -72%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$1.27M +$1.38M +264,300 New
AQR Capital Management
20
AQR Capital Management
Connecticut
$1.23M +$1.21M +233,422 +1,018%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.22M +$510K +97,931 +63%
Jane Street
22
Jane Street
New York
$1.1M +$1.03M +197,323 +626%
GCP
23
GSA Capital Partners
United Kingdom
$1.08M +$131K +25,130 +13%
Bank of America
24
Bank of America
North Carolina
$1.06M +$946K +181,781 +462%
UAS
25
United Asset Strategies
New York
$1.05M -$17.2K -3,300 -1%
1
2 3 4 5

HUMA Hedge Fund Activity: Q2 2024 in Review

123 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q2 2024, worth a combined $150M — up 107% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new HUMA positions and 17 closed out — a net gain of 29 holders — while 51 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $6.71M sold.

  • 123 institutional investors held Humacyte (HUMA) as of Q2 2024, up from 96 in Q1 2024.
  • Funds reported $150M of Humacyte stock for Q2 2024, up 107% quarter-over-quarter.
  • 46 funds opened new Humacyte positions in Q2 2024 and 17 closed out, a net change of +29 holders.
  • The largest Humacyte buyer in Q2 2024 was BlackRock, an estimated $12.2M added.
  • The largest Humacyte seller in Q2 2024 was AIGH Capital Management, an estimated $6.71M sold.

Based on aggregated 13F filings for Q2 2024.